脂蛋白和冠状动脉化:旋转动脉切除术患者的预后影响
Yaolin Chen1,2,3, Wei Gao2,3,4, Yinman Wang1,2,3,4
1Department of Cardiology, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, China.
概括
升高的脂蛋白[Lp[a]水平 (≥50 mg/dL) 与轮转性心脏切除术患者的重大心脏不良事件 (MACE) 有关. 显著升高的Lp (a) (≥68.3 mg/dL) 也预测心血管死亡,特别是在吸烟者和伴随疾病的人群中.
科学领域:
- 心脏病学 心脏病学
- 血管生物学 血管生物学
- 干预心脏病学 干预心脏病学
背景情况:
- 升高的脂蛋白 (Lp) 是已知的重大心脏不良事件 (MACE) 的风险因素.
- 在接受旋转性心脏切除术 (RA) 的严重冠状动脉化的患者中,Lp (a) 的预后作用尚不清楚.
- 本研究调查了Lp(a) 水平与RA后临床结果在这个特定患者队列之间的关联.
研究的目的:
- 为了确定Lipoprotein (a) [Lp (a) ]的预后值,在轮转性切除术 (RA) 后患有严重冠状动脉结的患者.
- 评估Lp(a) 水平与主要心脏不良事件 (MACE) 和心血管死亡 (CVD) 风险之间的关系.
主要方法:
- 对494名接受了RA的患者的数据进行了回顾性分析.
- 将Lp (a) 水平分层为<50 mg/dL和≥50 mg/dL的类别.
- 评估MACE和CVD作为主要结局,并进行生存分析和Cox回归.
主要成果:
- 患有Lp (a) ≥50 mg/dL的患者显示MACE的发生率显著更高 (日志排名p=0.006).
- 确定了心血管疾病的最佳值为68.3 mg/dL,其中Lp (a) ≥68.3 mg/dL与心血管疾病风险增加有关 (逻辑等级p=0.02).
- Lp (a) 是MACE的独立风险因素,特别是在吸烟者和患有并发症的患者中.
结论:
- Lp (a) ≥50 mg/dL与MACE在经历RA的严重冠状动脉化患者中独立相关.
- 显著升高的Lp(a) 水平 (≥68.3 mg/dL) 与心血管死亡有关.
- Lp (a) 确定了MACE风险较高的子组,包括吸烟者和患有并发症的人.
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
130
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
130
Coronary Artery Disease II: Pathophysiology
44
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
44
Coronary Artery Disease IV: Preventive Measures
40
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
40
Coronary Artery Disease I: Introduction
69
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Atherosclerosis I: Introduction
97
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
97


